![]() |
市場調查報告書
商品編碼
1451173
2024-2032 年按測試類型、產品類型、技術類型、最終用戶和地區分類的凝血分析儀市場報告Coagulation Analyzer Market Report by Testing Type, Product Type, Technology Type, End User, and Region 2024-2032 |
2023年,全球凝血分析儀市場規模達到58億美元。展望未來, IMARC Group預計到2032年市場規模將達到108億美元,2024-2032年複合年成長率(CAGR)為7%。
凝血,也稱為血液學,是使血液形成凝塊以治癒傷口的過程。醫師主要使用凝血分析儀對血球進行定量和分類。進行不同類型的凝血試驗,如PT、APTT、ACT等,以評估患者的凝血功能。大多數血液分析儀能夠提供有關紅血球 (RBC) 中血紅蛋白、紅血球資料、血小板計數和血細胞比容水平的資訊。然而,已經開發了一些新機器來測量兩種特殊的細胞類型,其中包括有核紅血球和未成熟的白血球。目前,由於患有血液疾病和生活方式疾病的人口持續成長,凝血分析儀的需求正在增加。
在過去的十年中,技術的快速進步和新的凝血分析儀測試的引入提高了止血實驗室的品質和效率。一些現代複雜混凝器還具有高通量、靈活性和可靠性。除此之外,它們還提供了更高的準確度和精確度,以及易於使用的高級軟體,並配有內建圖形和校準曲線。此外,心臟病和血液疾病的盛行率顯著上升,這導致全球範圍內需要改進的凝血分析儀。除此之外,凝血分析儀的銷售也受到全球越來越多的醫院、診斷中心和研究機構的正面影響。
The global coagulation analyzer market size reached US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032.
Coagulation, also known as hematology, is a process that enables the blood to create a clot to heal a wound. Physicians primarily use coagulation analyzers for quantifying and classifying blood cells. Different types of coagulation tests, such as PT, APTT, ACT, etc., are carried out for assessing blood clotting function in patients. Most of the hematology analyzers are capable of providing information about hemoglobin in red blood cells (RBCs), corpuscular data, platelet counts and hematocrit levels. However, some new machines have been developed to measure two specialized cell types, which include nucleated RBCs and immature white cells. At present, coagulation analyzers are experiencing a rise in their demand on account of consistent growth in the population suffering from blood disorders and lifestyle diseases.
Over the past decade, rapid advancements in technology and the introduction of new coagulation analyzer tests have led to an increase in the quality and efficiency of hemostasis laboratories. Some of the modern complex coagulators also possess high throughput, flexibility and reliability. Other than this, they provide improved accuracy and precision, and easy-to-use advanced software provided with in-built graphs and calibration curves. Moreover, there has been a significant rise in the prevalence of cardiac diseases and blood disorders, which has created the need for improved coagulation analyzers across the globe. Besides this, the sales of coagulation analyzers are positively being influenced by the increasing number of hospitals, diagnostic centers and research institutes established worldwide.
IMARC Group provides an analysis of the key trends in each sub-segment of the global coagulation analyzer market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on testing type, product type, technology type and end user.
Prothrombin Time Testing (PT)
Fibrinogen Testing
Activated Partial Thromboplastin Time Testing (APTT)
Activated Clotting Time Testing (ACT)
D-Dimer Testing
Platelet Function Testing
Anti-Factor Xa Testing
Others
Instruments/Analyzers
Automated Analyzers
Semi-Automated Analyzers
Manual Analyzers
Reagents
Consumables
Others
Optical Technology
Mechanical Technology
Electrochemical Technology
Others
Clinical Laboratories
Diagnostic Centers
Hospitals
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Roche Diagnostics (F. Hoffmann-La Roche Ltd.), Nihon Kohden, Sysmex Corporation, Siemens Healthineers Company, Thermo Fisher Scientific Inc., Helena Laboratories Corporation, DIAGNOSTICA STAGO, Instrumentation Laboratory Company, etc.